Stock data
Takeda Pharmaceutical Company$27.00
4502 
0.21% • 24 H
0.21% • 24 HDividend Yield:4.2%
Global Rank#416
Market Cap$41.91B
YTD Performance3.09%
P/E0.13
Revenue$25.65B
Change 7d3.69%
SP500 BenchmarkUnderperform
Country🇯🇵 Japan
P/S1.63
Earnings$2.02B
Dividend Yield:4.2%
Main Sector
Healthcare
Takeda Pharmaceutical Company 4502 Total Debt
4502 Total Debt in 2022: $25.74B
According to Takeda Pharmaceutical Company latest financial reports the total debt is $25.74B, an decrease of -2.38% to 2022. At the end of 2022 company had $26.37B total debt. This figure represents the debts and financial obligations that Takeda Pharmaceutical Company combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Takeda Pharmaceutical Company 4502 Total Debt History from 2023 to 2022
-
Value:-
4502 Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $25.74B | -2.38% |
| 2022 | $26.37B | -10.23% |
| 2021 | $29.38B | 2.37% |
| 2020 | $28.70B | -5.45% |
| 2019 | $30.35B | - |
View the Top Total Debt Stocks 
